Kuros Biosciences

medical devices

About

Kuros Biosciences AG is a biotechnology and MedTech company based in Switzerland, specializing in regenerative medicine. Founded in 2001 as a spin-off from the Swiss Federal Institute of Technology in Zurich, Kuros focuses on innovative biologic technologies for bone and tissue healing, particularly in spinal fusion and orthopedic applications. The company is publicly listed on the SIX Swiss Exchange under the ticker symbol KURN and operates globally across three continents. Kuros's flagship product line, MagnetOs®, is a bone graft substitute that promotes bone growth and spinal fusion, featuring proprietary NeedleGrip™ surface technology. The product range includes MagnetOs Granules, MagnetOs Putty, and MagnetOs Flex Matrix, all cleared by the FDA for various applications. The company also has a biologics platform strengthened by the acquisition of Xpand Biotechnology in 2017. Kuros serves orthopedic surgeons, hospitals, and healthcare providers, aiming to improve patient outcomes in bone repair surgeries through its advanced biologic products and strategic partnerships, including an exclusive agreement with Medtronic’s spinal division.

Technologies

Amazon SES Outlook Microsoft Office 365 WordPress.org Google Tag Manager YouTube Typekit Hubspot The Trade Desk Linkedin Marketing Solutions Apache Google Analytics Mobile Friendly Remote Circle AI

Keywords

medical devices orthobiologics biotechnology bone spine orthopedics neurosurgery foot ankle bone healing spine surgery musculoskeletal orthopaedics biologics spine fusion medical equipment manufacturing regenerative medicine biotech company bone graft bone graft with proprietary surface tech services bone regeneration studies surgical solutions orthopedic surgery bone healing products biologic implants clinical validation b2b bone regeneration in smokers global market

Location

25 Wagistrasse, Schlieren, Zurich, Switzerland, 8952

Related Companies

Companies in the same industry